Get the Stockscreener App
0.7442
0.69%
-0.0052
After Hours:
.74
-0.0042
-0.56%
Pasithea Therapeutics Corp stock is traded at $0.7442, with a volume of 39,146.
It is down -0.69% in the last 24 hours and down -3.45% over the past month.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
See More
Previous Close:
$0.7494
Open:
$0.7269
24h Volume:
39,146
Relative Volume:
0.33
Market Cap:
$5.54M
Revenue:
-
Net Income/Loss:
$-16.28M
P/E Ratio:
-0.0535
EPS:
-13.91
Net Cash Flow:
$-13.75M
1W Performance:
-9.52%
1M Performance:
-3.45%
6M Performance:
-47.59%
1Y Performance:
-84.43%
1-Day Range:
$0.7269
$0.7499
1-Week Range:
$0.7269
$0.84
52-Week Range:
$0.65
$4.73
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Name
Pasithea Therapeutics Corp
Sector
Industry
Phone
(702) 514-4174
Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7442 | 5.58M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pasithea Therapeutics Corp Stock (KTTA) Latest News
Institutional scanner results for Pasithea Therapeutics Corp.Market Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Is Pasithea Therapeutics Corp. stock a dividend growth opportunityWeekly Stock Recap & Growth Focused Entry Reports - newser.com
How Pasithea Therapeutics Corp. Equity Warrant stock trades during market volatilityMarket Growth Report & Safe Swing Trade Setups - newser.com
How Pasithea Therapeutics Corp. stock performs in interest rate cyclesMarket Performance Report & Long-Term Capital Growth Strategies - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock trend forecastLong Setup & Technical Pattern Alert System - newser.com
Pasithea Therapeutics Corp.’s volatility index tracking explained2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - newser.com
Using flow based indicators on Pasithea Therapeutics Corp.Portfolio Return Report & Low Drawdown Trading Techniques - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. lossesPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Understanding Pasithea Therapeutics Corp. Equity Warrant’s price movement2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Pasithea Therapeutics Corp Stock Analysis and ForecastStock Buy Signals & Maximize Returns With Insights - earlytimes.in
What risks investors should watch in Pasithea Therapeutics Corp. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com
Is Pasithea Therapeutics Corp. forming a bottoming baseJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-10 08:53:04 - newser.com
Will a bounce in Pasithea Therapeutics Corp. offer an exitWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Short interest data insights for Pasithea Therapeutics Corp. Equity Warrant2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
How currency fluctuations impact Pasithea Therapeutics Corp. stockTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Will Pasithea Therapeutics Corp. stock maintain dividend yield2025 Earnings Surprises & Weekly Return Optimization Alerts - newser.com
What moving averages say about Pasithea Therapeutics Corp.2025 Analyst Calls & Long-Term Safe Investment Plans - newser.com
Can Pasithea Therapeutics Corp. stock rebound after recent weakness2025 Trade Ideas & Weekly Momentum Picks - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock deliver strong dividend growthQuarterly Profit Review & Real-Time Stock Entry Alerts - newser.com
Chart based exit strategy for Pasithea Therapeutics Corp.Weekly Market Summary & AI Enhanced Trading Signals - newser.com
Multi asset correlation models including Pasithea Therapeutics Corp. Equity WarrantWeekly Profit Report & Verified Entry Point Detection - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. Equity Warrant lossesPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-10-09 02:47:31 - newser.com
Pasithea Therapeutics Corp. stock daily chart insightsQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastFederal Reserve Announcements & Get Tomorrow’s Winners Today With AI - earlytimes.in
What recovery options are there for Pasithea Therapeutics Corp.Product Launch & Free Community Supported Trade Ideas - newser.com
Is a relief rally coming for Pasithea Therapeutics Corp. Equity Warrant holdersJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Real time breakdown of Pasithea Therapeutics Corp. stock performanceMarket Risk Analysis & High Conviction Investment Ideas - newser.com
Is it time to cut losses on Pasithea Therapeutics Corp.July 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Using R and stats models for Pasithea Therapeutics Corp. forecasting2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
How Pasithea Therapeutics Corp. stock responds to policy changesJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Can technical indicators confirm Pasithea Therapeutics Corp. Equity Warrant’s reversalJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Trend analysis for Pasithea Therapeutics Corp. this weekWall Street Watch & Weekly Top Stock Performers List - newser.com
What Makes Three M Paper Boards Limited Stand Out Among CompetitorsVolume Weighted Average Price & Maximum Profit Growth - earlytimes.in
Using Bollinger Bands to evaluate Pasithea Therapeutics Corp.2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Tick level data insight on Pasithea Therapeutics Corp. volatilityGDP Growth & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp. Equity Warrant2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Pasithea Therapeutics Corp. stock trendline breakdownWeekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Pasithea Therapeutics (NASDAQ:KTTA) Shares Up 2.5% – Here’s Why - Defense World
Pasithea Therapeutics Corp Stock (KTTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pasithea Therapeutics Corp Stock (KTTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):